Create a FREE Provider account to access the Case Reviews.Get a Curriculum Login
QUESTIONS or TECHNICAL ISSUES?
Contact: 202-232-6749 or Opioids@HealthHIV.org
How to Access the Case Reviews
- Step 1: Register for the Case Reviews Curricula
- All participants must register for the curriculum to gain access to the courses
- Click the “Register for the Curriculum” button above
- Complete the form fields to register for the curriculum and create an account
- Click “Submit”
- If you already have an account: Click “Log-in” at the top right of the form. Complete the form if you are prompted to – this will register your account for the curriculum. Click “Submit”.
- Step 2: Access Individual Courses
- After you have registered for the case review by following the steps above, you can access the case review sessions by either:
- Logging in to the learning management system and finding the courses under “Learning”, or
- Returning to this page, selecting one of the courses below, and clicking “Open Course”
- After you have registered for the case review by following the steps above, you can access the case review sessions by either:
Target Audience
This activity is intended for doctors, physician assistants, advanced practice registered nurses, registered nurses, pharmacists, psychologists and social workers engaged in the treatment of opioid use disorders
Education Objectives
After completing this activity, the participant should be better able to:
- ModuleLearning ObjectivesAccreditation Details
- Case Review – Session 1Open this module→
- Review the latest research and discuss advances in relation to treating individuals with opioid use disorder.
- Facilitate discussions surrounding difficulties in treating opioid use disorder in relation to specific patient cases including:
- Barriers to care
- Treatment plans
- Treatment plan challenges
May 5, 2020Expiration Date:
May 4, 2021
UAN #:
JA4008162-9999-20-2005-H02-P - Case Review – Session 2Open this module→
- Review the latest research and discuss advances in relation to treating individuals with opioid use disorder.
- Facilitate discussions surrounding difficulties in treating opioid use disorder in relation to specific patient cases including:
- Barriers to care
- Treatment plans
- Treatment plan challenges
July 8, 2020Expiration Date:
July 7, 2021
UAN #:
JA4008162-9999-20-2069-H01-P - Case Review – Session 3Open this module→
- Review the latest research and discuss advances in relation to treating individuals with opioid use disorder.
- Facilitate discussions surrounding difficulties in treating opioid use disorder in relation to specific patient cases including:
- Barriers to care
- Treatment plans
- Treatment plan challenges
September 30, 2020Expiration Date:
September 29, 2021
UAN #:
JA4008162-9999-20-2205-H01-P - Case Review – Session 4Open this module→
- Review the latest research and discuss advances in relation to treating individuals with opioid use disorder.
- Facilitate discussions surrounding difficulties in treating opioid use disorder in relation to specific patient cases including:
- Barriers to care
- Treatment plans
- Treatment plan challenges
September 30, 2020Expiration Date:
September 29, 2021
UAN #:
JA4008162-9999-20-2367-H01-P
Faculty
Seth Rosenblatt, MD
Psychiatrist, Whitman Walker Health
Elana Rosenthal, MD
Co-director, DC Partnership for HIV/AIDS, Hepatitis Clinical Research Program
Assistant Professor, Institute of Human Virology, Division of Infectious Diseases
University of Maryland
Katherine Saavedra, PA
Family Practice Physician Assistant
Mary’s Center
Mari Lowe, NP
Unity Healthcare
Michael Shankle
Senior Director of Capacity Building
HealthHIV
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education (AMA)
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education (ACPE)
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Nursing Education (ANCC)
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hour. Designated for .1 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.
Continuing Physician Assistant Education (AAPA)
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until May 4, 2021. PAs should only claim credit commensurate with the extent of their participation.
Continuing Psychologist Education (APA)
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibly for the content of the programs.
Continuing Social Worker Education (NASW)
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 clinical continuing education credits.
Disclosure of Conflict of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and is not a specific proprietary business of commercial interest.
Faculty
Mari Lowe, NP discloses salary for Unity Health Care (self) and American University (spouse)
Seth Rosenblatt, MD has nothing to disclose
Elana Rosenthal, MD has nothing to disclose
Katherine Saavedra, PA has nothing to disclose
Michael Shankle has nothing to disclose
Planners and Manager
The PIM planners and managers have nothing to disclose.
Media
Internet
Computer System Requirements
Participants will need access to a computer with audio and video capabilities or a phone.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.